跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
阿法根 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Brimonidine Tartrate Eye Drops
Approved
化学药品
Brimonidine Tartrate Eye Drops
AbbVie Limited
🇨🇳 National Medical Products Administration
Approval Date
Jun 28, 2021
Approval ID
8DqlfqbKVvH
Company
AbbVie Limited
Type
化学药品
Approval Details
Approval Id
8DqlfqbKVvH
Approval Number
国药准字HJ20160681
Generic Name
酒石酸溴莫尼定滴眼液
Generic Name En
Brimonidine Tartrate Eye Drops
Trade Name
阿法根
Drug Type
化学药品
Dosage Form
眼用制剂
Strength
5ml:10mg
Reg Date
2021-06-28
Expired Date
2026-06-27
Company Name
AbbVie Limited
Production Company Name
Allergan Pharmaceuticals Ireland
Company Detail Path
/organization/abbvie-limited
Production Company Detail Path
/organization/allergan-pharmaceuticals-ireland
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 28, 2021
Approval ID
8DqlfqbKVvH
Type
化学药品
Back to NMPA Approvals